A novel splicing mutation in the V2 vasopressin receptor

Pediatric Nephrology

Volumn 15, Issue 1-2, 2000, Pages 43-49

  Kamperis, K ^a   Siggaard, C ^a   Herlin, T ^a   Nathan, E ^a   Hertz, J M ^a   Rittig, S ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Clinical phenotype; DNA sequencing; Nephrogenic diabetes insipidus; Vasopressin receptor type 2

Indexed keywords

ARGIPRESSIN; ARGIPRESSIN RECEPTOR; ARGIPRESSIN RECEPTOR 2; DESMOPRESSIN; RECEPTOR SUBTYPE; UNCLASSIFIED DRUG; VASOPRESSIN V2 RECEPTOR; WATER;

ARTICLE; CASE REPORT; DIAGNOSTIC PROCEDURE; DNA SEQUENCE; FAMILY STUDY; GENE MUTATION; GENETIC ANALYSIS; HUMAN; INFANT; INTRON; MALE; NEPHROGENIC DIABETES INSIPIDUS; NUCLEOTIDE SEQUENCE; PHENOTYPE; POINT MUTATION; PRIORITY JOURNAL; RNA SPLICING; WATER DEPRIVATION; X CHROMOSOME RECESSIVE DISORDER;

EID: 0033675477     PISSN: 0931041X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004670000431     Document Type: Article

References (30)

1. Notes on some cases of diabetes insipidus with marked family and hereditary tendencies
2. Vasopressin receptor mutations causing nephrogenic diabetes insipidus
3. The molecular basis of nephrogenic diabetes insipidus
4. An aquaporin-2 water channel mutant which causes autosomal dominant nephrogenic diabetes insipidus is retained in the Golgi complex
5. An impaired routing of wild-type aquaporin-2 after tetramerization with an aquaporin-2 mutant explains dominant nephrogenic diabetes insipidus
6. Molecular cloning of the receptor for human antidiuretic hormone
7. Structure and chromosomal localization of the human antidiuretic hormone receptor gene
8. Cloning and characterization of a vasopressin V2 receptor and possible link to nephrogenic diabetes insipidus
9. Localization of the gene for X-linked nephrogenic diabetes insipidus to Xq28
10. Assignment of the human gene for the water channel of renal collecting duct Aquaporin 2 (AQP2) to chromosome 12 region q12→q13
11. The effect of eight V2 vasopressin receptor mutations on stimulation of adenylyl cyclase and binding to vasopressin
12. Expression studies of two vasopressin V2 receptor gene mutations, R202C and 804insG, in nephrogenic diabetes insipidus
13. Functional characterization of five V2 vasopressin receptor gene mutations
14. Functional studies of twelve mutant V2 vasopressin receptors related to nephrogenic diabetes insipidus: Molecular basis of a mild clinical phenotype
15. AVPR2 variants and V2 vasopressin receptor function in nephrogenic diabetes insipidus
16. Mechanism of vasopressin natriuresis in the dog: Role of vasopressin receptors and prostaglandins
17. Familial neurohypophyseal diabetes insipidus associated with a signal peptide mutation
18. Mutations in the vasopressin V2 receptor and aquaporin-2 genes in 12 families with congenital nephrogenic diabetes insipidus
19. Mutations in the V2 vasopressin receptor gene are associated with X-linked nephrogenic diabetes insipidus
20. Heterogeneous AVPR2 gene mutations in congenital nephrogenic diabetes insipidus
21. The mutational spectrum of single base-pair substitutions in mRNA splice junctions of human genes: Causes and consequences
22. Construction of a novel database containing aberrant splicing mutations of mammalian genes
23. Exon recognition in vertebrate splicing
24. A dileucine sequence and an upstream glutamate residue in the intracellular carboxyl terminus of the vasopressin V2 receptor are essential for cell surface transport in COS.M6 cells
25. Identification of residues responsible for the selective binding of peptide antagonists and agonists in the V2 vasopressin receptor
26. A serine cluster prevents recycling of the V2 vasopressin receptor
27. Detection of skewed X-inactivation in two female carriers of vasopressin type 2 receptor gene mutation
28. Proposed cause of marked vasopressin resistance in a female with an X-linked recessive V2 receptor abnormality
29. Hemodynamic and coagulation responses to 1-desamino[8-D-arginine] vasopressin in patients with congenital nephrogenic diabetes insipidus
30. Pharmacokinetics and haematological effects of desmopressin